{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Drugs 2017, Part 2
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide information about seven newly approved drugs and their nursing considerations.Learning Objectives
After completing this continuing education activity you will be able to:
- Describe the indications for seven newly approved drugs.
- Identify nursing implications for these new drugs.
Disclosures
The author and planners have disclosed no potential conflicts of interest, financial or otherwise.
Price:
$17.95
Credits:
- ANCC 1.5 CH / 1.5 APH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.
Awarded Advanced Pharmacology Pharmacology
Awarded Advanced Pharmacology Pharmacology
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: N0717A
Published: Jul 2017
Expires: 1/1/2026
Sources:
Nursing2020
Required Passing Score: 13/18 (72%)
Specialties:
Primary Care